Rv1630 - p.Asp335Glu
Drug resistance types
0 Sensitive
7 RR-TB
1 HR-TB
10 MDR-TB
0 Pre-XDR-TB
0 XDR-TB
1 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.8.1 | 2 |
| lineage4.3.3 | 2 |
| lineage4.9 | 1 |
| lineage4.2.2.2 | 1 |
| lineage2.2.1 | 1 |
| lineage4.8 | 4 |
| lineage4.4.1.1.1 | 2 |
| lineage4.1.1.3 | 1 |
| lineage4.6.2.2 | 1 |
| lineage2.2.2 | 1 |
| lineage2;lineage4 | 1 |
| lineage4.1.1.1 | 1 |
| lineage4.4 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 19 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR11342693 | MDR-TB | lineage4.8.1 | None | SRR11342649 | MDR-TB | lineage4.3.3 | None | SRR1735596 | RR-TB | lineage4.9 | None | SRR11342687 | RR-TB | lineage4.2.2.2 | None | SRR11342660 | MDR-TB | lineage2.2.1 | None | ERR978766 | RR-TB | lineage4.8 | None | SRR11342644 | MDR-TB | lineage4.4.1.1.1 | None | SRR11342696 | MDR-TB | lineage4.4.1.1.1 | None | SRR11342647 | MDR-TB | lineage4.1.1.3 | None | SRR11342676 | HR-TB | lineage4.6.2.2 | None | SRR11342664 | MDR-TB | lineage2.2.2 | None | SRR11342662 | MDR-TB | lineage4.8.1 | None | SAMEA3501073 | RR-TB | lineage4.8 | None | ERR978767 | RR-TB | lineage4.8 | None | ERR1023502 | MDR-TB | lineage2;lineage4 | None | SRR11342642 | MDR-TB | lineage4.1.1.1 | None | SRR16627752 | RR-TB | lineage4.4 | None | ERR4818583 | Other | lineage4.3.3 | None | ERR978767_ERR978765_ERR978766 | RR-TB | lineage4.8 | None |
|---|
